ArticleEye (London, England)2022

Response to: 'Comment on: 'Dupilumab-associated ocular surface disease: presentation, management and long-term sequelae''.

Magdalena Popiela et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.